{"id":"NCT00674362","sponsor":"UCB Pharma","briefTitle":"Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study","officialTitle":"A Phase IIIB, Multi-center, Double-blind, Placebo-controlled, Parallel Group, 52-week Study to Evaluate the Safety and Efficacy of Certolizumab Pegol, Administered With DMARDs, in Patients With Low to Moderate Disease Activity Rheumatoid Arthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-06","primaryCompletion":"2010-05","completion":"2010-12","firstPosted":"2008-05-07","resultsPosted":"2012-01-18","lastUpdate":"2012-01-18"},"enrollment":194,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"BIOLOGICAL","name":"Certolizumab pegol","otherNames":["CDP870","Cimzia"]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"Certolizumab pegol 200 mg (CDP870)","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To assess the clinical efficacy and safety of certolizumab pegol as add-on therapy with stable-dose disease-modifying antirheumatic drugs (DMARDs) for achieving clinical remission in patients with moderate to low disease activity rheumatoid arthritis","primaryOutcome":{"measure":"Clinical Disease Activity Index (CDAI) Remission (â‰¤2.8) at Both Week 20 and Week 24","timeFrame":"Week 20 and Week 24","effectByArm":[{"arm":"Certolizumab Pegol 200 mg (CDP870)","deltaMin":18.8,"sd":null},{"arm":"Placebo","deltaMin":6.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":3},"locations":{"siteCount":31,"countries":["Austria","France","Germany","Italy","Poland"]},"refs":{"pmids":["24431394"],"seeAlso":["http://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":96},"commonTop":["Nasopharyngitis","Nausea","Urinary Tract Infection","Diarrhoea","Upper Respiratory Tract Infection"]}}